Ecdysone-based system for controlled inducible expression of metabotropic glutamate receptor subtypes 2, 5, and 8

Journal of Biomolecular Screening

Volumn 10, Issue 8, 2005, Pages 841-848

  Downey, Patrick M ^a,b   Lozza, Gianluca ^a   Petrò, Roberta ^a   Diodato, Enrica ^a   Foglia, Chiara ^a   Bottazzoli, Federica ^a   Brusa, Rossella ^a   Asquini, Tatiana ^a   Reggiani, Angelo ^a   Grilli, Mariagrazia ^a  

^a Neurobiology Research   (Italy)

^b Schering Plough Research Institute   (Italy)

Author keywords

Chimeric G proteins; Inducible expression; Metabotropic glutamate receptors

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; 2 (2,3 DICARBOXYCYCLOPROPYL)GLYCINE; 2 (CARBOXYCYCLOPROPYL)GLYCINE; 2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 AMINO 4 PHOSPHONOBUTYRIC ACID; 2 CHLORO 5 HYDROXYPHENYLGLYCINE; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 3 [(2 METHYL 4 THIAZOLYL)ETHYNYL]PYRIDINE; 3,4 DICARBOXYPHENYLGLYCINE; 4 PHOSPHONOPHENYLGLYCINE; COMPLEMENTARY DNA; ECDYSONE; G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLYCINE DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 8; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; N ACETYLASPARTYLGLUTAMIC ACID; PONASTERONE A; QUISQUALIC ACID; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL CLONE; CELL LINE; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; EMBRYO; HUMAN; HUMAN CELL; NEUROTRANSMISSION; PRIORITY JOURNAL; WESTERN BLOTTING;

CALCIUM; CELL LINE; CLONING, MOLECULAR; ECDYSONE; ECDYSTERONE; GENE EXPRESSION; GTP-BINDING PROTEIN ALPHA SUBUNITS; HUMANS; RECEPTORS, METABOTROPIC GLUTAMATE; TRANSCRIPTION, GENETIC;

EID: 29144527051     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057105280285     Document Type: Article

References (39)

1. Nedergaard M.Takano T, Hanse AJ: Beyond the role of glutamate as a neurotransmiter. Nat Rev Neurosci 2002:3:748-755.
2. De Blasi A. Conn PJ. Pin J-P, Nicoletti F: Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci 2001;22:114-120.
3. Conn PJ. Pin J-P: Pharmacology and functions of metabotropic glutamate receptors. Anna Rev Pharmacol Toxicol 1997:3:205-237.
4. Conn PJ: Physiological roles and therapeutic potential of metabotropic glutamate receptors. Ann N Y Acad Sci 2003:1003:12-20.
5. Paul IA, Skolnick P: Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 2003:1003:250-272.
6. Bhave G, Karim F, Carlton SM, Gereau RW: Peripheral group 1 metabotropic glutamate receptors modulate nociception in mice. Nat Neurosci 2001:4:417-423.
7. Neugebauer V: Metabotropic glutamate receptors-important modulators of nociception and pain behavior. Pain 2002:98:1-8.
8. Fisher K, Lefebvre C, Coderre TJ: Antinociceptive effects following intrathecal pre-treatment with selective metabotropic glutamate receptor compounds in a rat model of neuropathic pain. Pharmacol Biochem Behav 2002:6677:1-8.
9. Sharpe EF, Kingston AB, Lodge D, Monn JA, Headley PM: Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo. BrJ Pharmacol 2002:135:1255-1262.
10. Dolan S, Nolan AM: Behavioural evidence supporting a differential role for spinal group I and II metabotropic glutamate receptors in inflammatory hyperalgesia in sheep. Neuropharmacology 2002:43:319-326.
11. Simnions RMA, Webster AA, Kalra AB, lyengar S: Group II mGluR receptor agonists arc effective in persistent and neuropathic pain models in rats. Pharmacol Biochem Behav 2002:73:419-427.
12. Klodzinska A, Chojnacka-Wojeik E, Palucha A, Branski P, Popik P, Pile A: Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models. Neuropharmacology 1999:38:1831-1839.
13. Linden AM, Johnson BG, Peters SC, Shannon HF, Tian M, Wang Y, et al: Increased anxiety-related behaviour in mice deficient for metabotropic glutamate 8 (mGlu8) receptor. Neuropharmacology 2002:43:251-259.
14. Palucha A, Tatarezynska F, Branski P, Szewczyk B, Wieronska JM, Klak K, et al: Group III mGlu receptor agonists produce anxiolytic and antidepressant-like effects after central administration in rats. Neuropharmacology 2004:46:151-159.
15. Desai MA, Burnett JP, Mayne NG, Schoepp DD: Cloning and expression of a human metabotropic glutamate receptor I alpha: enhanced coupling on cotransfection with a glutamate transporter. Mol pharmacol 1995:48:648-657.
16. No D, Yao T-P, Evans RM: Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad SCi USA 1996:93:3346-3351.
17. Conklin BR, Farfei Z, Lustig KD, Julius D, Bourne HR: Substitution of three amino acids switches receptor specificity of Gαq to that of Gαi. Nature 1993:363:274-276.
18. Minakami R, Katsuki F, Sugiyama H: A variant of metabotropic glutamate receptor subtype 5: an evolutionally conserved insertion with no termination codon. Biochem Biophys Rex Commun 1993:194:622-627.
19. Wu S, Wright RA, Rockey PK, Burgett SG, Arnold JS, Rosteek PR, et al: Group III human metabotropic glutamate receptors 4, 7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells. Mol Brain Rex 1998:53:88-97.
20. 35S]GTPγS binding assessment of metabotropic glutamate receptor standards in Chinese hamster ovary cell lines expressing the human metabotropic receptor subtypes 2 and 4. Neuropharmacology 1998:37:179-187.
21. Zhang J-H, Chung TDY, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999:4:67-73.
22. Balazs R, Miller S, Romano C, de Vries A, Chun Y, Corman CW: Metabotropic glutamate receptor mGluR5 in astrocytes: pharmacological properties and agonist potencies. J Neurochem 1997:69:151-163.
23. Daggett LP, Sacaan Al, Akong M, Rao SP, Hess SD, Liaw C, et al: Molecular and Functional characterization of recombinant human glutamate receptor subtype 5. Neuropharmacology 1995:34:871-886.
24. ;q′1 proteins: characterization of new antagonists. Mol Pharmacol 1996:50:923-930
25. Parmentier ML, Joly C, Restituito S, Boekaerl J, Grau Y, Pin J-P: The G protein-coupling profile of metabotropic glutamate receptors as determined with exogenous G protiens is independent of their ligand recognition domain. Mol Pharmacol 1998:53:778-786.
26. Knoflach K, Woltering T, Adam G, Mutel V, Kemp, JA: Pharmacological properties of native metabotropic glutamate receptors in Freshly dissociated golgi cells of the rat cerebellum. Neuropharmacology 2001:40:163-169.
27. Flor PJ, Lindaner K, Puttner I, Ruegg D, Lukic S, Knoptel T, et al: Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 2. Eur J Neurosci 1995:7:622-629.
28. Thomas NK, Wright RA, Howson PA, Kingslon AE, Schoepp DD, Jane DE: (S)-3.4-DCPG, a potent and selective mGlu8a receptor agonist activates metabotropic glutamale receptors on primary afferent terminals in the neonatal rat spinal cord. Neuropahrmacology 2001:40:311-318.
29. Malherbe P, Kratzeisen C, Lundstrom K, Richards JG, Faull RLM, Mutel V: Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8. Brain Res Mol Brain Res 1999:67:201-210.
30. Gasparini E, Lanngenhohl K, Stoehr N, Flor P.J, Heinrich M, Vranesic I, et al: 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGluR5 receptor antagonist. Neuropharmacology 1999:38:493-1503.
31. Litschig S. Gasparini F. Ruegg D. Stoehr N. Flor PJ. Vranesie I. et al: CPCCOEt, a non-competitive mGluRK I antagonist, inhibits receptor signaling without affecting glutamate binding. Mol Pharmacol 1999:55:453-461.
32. Knoflach F. Mutel V. Jolidon S. Kew JN. Malherbe P. Vieira E et al: Positive allosteric modulators of metabotropic glutamate I receptor: characterization. mechanism of action and binding site, Proc Natl Acad Sci U S A 2001:98:13402-13407.
33. Schaffhauser H. Rowe BA. Morales M. Chavez-Noriega LE. Yin R. Jachec C. et al: Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2. Mol Pharmacol 2003:64:798-810.
34. MaJ M. Bruno V. Dragie Z. Yamamoto R. Battaglia G. Inderbitzin W. et al: (-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action and neuroprotection. Neuropharmacology 2003:45:895-906.
35. O'Brien JA. Lemaire W. Chen T-B. Chang RSL. Jacobson MA. Ha SN. et al: A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5. Mol Pharmacol 2003:64:731-740.
36. Mathiesen JM. Svendsen N. Brauner-Oshorne H. Thomsen C. Ramirez MT: Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP. BrJ Pharmacol 2003:138:1026-1030.
37. Van Craenenbroeck K. Vanhoenacker P. Leysen JE Haegeman G: Evaluation of the tetracycline and ecdysone-inducible systems for expression of neurotransmitter receptors in mammalian cells. Eur J Neurosci 2001:14:968-976.
38. Senner V. Sotoodeh A. Paulus W: Regulated gene expression in glioma cells: a comparison of three inducible systems. Nuerochem Res 2001:5:521-524.
39. Xu Z. Mizuguch H. Mayumi T. Hayakawva T: Regulated gene expression from adenovirus vectors: a systematic comparison of various inducible systems. Gene 2003:309:145-151.